Pharma Value will participate in ISPOR Europe 2023which will be held from 12 to 15 November 2023 in Copenhagen.

Flying to Denmark are Ginevra Mastroianni, Institutional and Regulatory Affairs Manager and Federico Tartarelli, Market Access Specialist of the Pharma Value team.

In particular Federico will be present at the Poster Session on 13 November 2023 from 10:30 a.m. to 1:30 p.m. (abstract ID 131988 titled Evolution of the Utilisation of the Aifa 5% Fund for Orphan Drugs and Rare Diseases) and will give its presentation on the same day from 12:30 to 1:30 p.m.

Geneva instead will be present at the Poster Session on 14 November 2023 from 10:30 a.m. to 1:30 p.m. (abstract ID 131491 titled Regional Access Timelines in Italy: Factors Affecting Speed and Equity) and will give its presentation again on 14 November from 12:30 to 1:30 p.m.

ISPOR Europe is one of the leading European conferences for health economics and outcomes research (HEOR) that Pharma Value did not want to miss. You can find the full programme of the November conference at ISPOR Europe.

Also in March this year, the team Pharma Value participated to another international event, the World Evidence, Pricing and Access Congress - EPA Congressduring which he learnt about the Next steps for the revision of the Orphan Drug Regulation.

Participation in international conferences and events is one of the working methods Pharma Value uses to get to know and network with other consulting firms and pharmaceutical companies, to improve its technical knowledge and to be constantly updated on the principles of pharmaceutical consulting, institutional relations and regulatory activities, aimed at market access, particularly in the Italian regulatory context, but also internationally.